Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34797 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Mi Na Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Diabetes Mellitus, Hepatitis, Viral, Human. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Mi Na Kim
Zitieren
APA
Kim, M. N., Zhang, X., & Ahn, S. H. (2024). Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”. International Journal of Cancer. https://doi.org/10.1002/ijc.34797
Vancouver
Kim MN, Zhang X, Ahn SH. Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”. International Journal of Cancer. 2024. doi:10.1002/ijc.34797
BibTeX
@article{Kim2024,
author = {Kim, Mi Na and Zhang, Xuehong and Ahn, Sang Hoon},
title = {Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34797}
}
EUVIMED